CTOs on the Move

NextStep Arthropedix

www.nextsteparthropedix.com

 
NextStep Arthropedix is a medical device manufacturer focused on designing, developing, manufacturing, and distributing joint replacement implant and instrument products for hip and knee arthroplasty. This company is at the forefront of designing and manufacturing innovative implants characterized by the advantages of 3D printing technology.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Microline Pentax Inc

Microline Pentax Inc is a Beverly, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Major's Wholesale Medical Supply

Major's Wholesale Medical Supply is a Ontario, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PetVivo

PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo`s strategy is to in-license proprietary products from human medical device companies specifically for use in pets. PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.

EnteroMedics

EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. vBloc Therapy is now approved by the Food and Drug Administration for weight loss in adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels.* *Individuals should have first tried to lose weight by diet and exercise in a supervised program within the last 5 years before receiving the Maestro System.

Karl Storz - Endoskope

Karl Storz - Endoskope is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.